The store will not work correctly when cookies are disabled.
(4-Aminophenyl)(3,9-diazaspiro[5.5]undecan-3-yl)methanone
ID: ALA5205502
PubChem CID: 168296725
Max Phase: Preclinical
Molecular Formula: C16H23N3O
Molecular Weight: 273.38
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ccc(C(=O)N2CCC3(CCNCC3)CC2)cc1
Standard InChI: InChI=1S/C16H23N3O/c17-14-3-1-13(2-4-14)15(20)19-11-7-16(8-12-19)5-9-18-10-6-16/h1-4,18H,5-12,17H2
Standard InChI Key: YIJURGQIKYCWEG-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
20.7802 -18.1627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4952 -18.5743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2072 -18.1666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2104 -17.3417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4955 -16.9261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7772 -17.3394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3543 -18.1627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3543 -18.9899 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0688 -19.3974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7834 -18.9899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0688 -17.7429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9243 -16.9279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9265 -16.1006 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6346 -17.3396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6329 -18.1638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3447 -18.5756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0587 -18.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0564 -17.3369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3440 -16.9289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7719 -18.5751 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 10 1 0
10 1 1 0
1 11 1 0
4 12 1 0
12 13 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 14 1 0
17 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 273.38 | Molecular Weight (Monoisotopic): 273.1841 | AlogP: 1.87 | #Rotatable Bonds: 1 |
Polar Surface Area: 58.36 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.33 | CX LogP: 0.74 | CX LogD: -2.02 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.77 | Np Likeness Score: -0.68 |
References
1. Bavo F, de-Jong H, Petersen J, Falk-Petersen CB, Löffler R, Sparrow E, Rostrup F, Eliasen JN, Wilhelmsen KS, Barslund K, Bundgaard C, Nielsen B, Kristiansen U, Wellendorph P, Bogdanov Y, Frølund B.. (2021) Structure-Activity Studies of 3,9-Diazaspiro[5.5]undecane-Based γ-Aminobutyric Acid Type A Receptor Antagonists with Immunomodulatory Effect., 64 (24.0): [PMID:34908407] [10.1021/acs.jmedchem.1c00290] |